TACE treatment in hepatocellular carcinoma: What should we do now?

被引：21

作者：

Farinati, Fabio ^{[1
]}

Giacomin, Anna ^{[1
]}

Vanin, Veronica ^{[1
]}

Giannini, Edoardo ^{[2
]}

Trevisani, Franco ^{[3
]}

机构：

[1] Univ Padua, Dept Surg & Gastroenterol Sci, Gastroenterol Sect, Padua, Italy

[2] Univ Genoa, Dept Internal Med, Gastroenterol Sect, I-16126 Genoa, Italy

[3] Alma Mater Studiorum Univ Bologna, Dept Clin Med, Bologna, Italy

来源：

JOURNAL OF HEPATOLOGY | 2012年 / 57卷 / 01期

关键词：

TRANSARTERIAL LIPIODOL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

D O I：

10.1016/j.jhep.2011.12.022

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：221 / 222

页数：2

共 10 条

[1] Transarterial chemoembolization for unresectable hepatocellular carcinoma:: Meta-analysis of randomized controlled trials [J].

Cammà, C ;

Schepis, F ;

Orlando, A ;

Albanese, M ;

Shahied, L ;

Trevisani, F ;

Andreone, P ;

Craxì, A ;

Cottone, M .

RADIOLOGY, 2002, 224 (01) :47-54

[2] Multicentre randomised phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (federation francophone de cancerologie digestive 9402) [J].

Doffoel, M. ;

Bonnetain, F. ;

Bouche, O. ;

Vetter, D. ;

Abergel, A. ;

Fratte, S. ;

Grange, J. D. ;

Stremsdoerfer, N. ;

Blanchi, A. ;

Bronowicki, J. P. ;

Caroli-Bosc, F. X. ;

Causse, X. ;

Masskouri, F. ;

Rougier, P. ;

Bedenne, L. .

EUROPEAN JOURNAL OF CANCER, 2008, 44 (04) :528-538

[3]

Eccles Martin, 2002, J Health Serv Res Policy, V7, P98, DOI 10.1258/1355819021927746

[4] Chemoembolization for intermediate HCC: Is there proof of survival benefit? [J].

Forner, Alejandro ;

Llovet, Josep M. ;

Bruix, Jordi .

JOURNAL OF HEPATOLOGY, 2012, 56 (04) :984-986

[5] Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival [J].

Llovet, JM ;

Bruix, J .

HEPATOLOGY, 2003, 37 (02) :429-442

[6] Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial [J].

Llovet, JM ;

Real, MI ;

Montaña, X ;

Planas, R ;

Coll, S ;

Aponte, J ;

Ayuso, C ;

Sala, M ;

Muchart, J ;

Solà, R ;

Rodés, J ;

Bruix, J .

LANCET, 2002, 359 (9319) :1734-1739

[7] Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma [J].

Lo, CM ;

Ngan, H ;

Tso, WK ;

Liu, CL ;

Lam, CM ;

Poon, RTP ;

Fan, ST ;

Wong, J .

HEPATOLOGY, 2002, 35 (05) :1164-1171

[8] Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma [J].

Oliveri, Roberto S. ;

Wetterslev, Jorn ;

Gluud, Christian .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (03)

[9] A RANDOMIZED TRIAL OF HEPATIC ARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA [J].

PELLETIER, G ;

ROCHE, A ;

INK, O ;

ANCIAUX, ML ;

DERHY, S ;

ROUGIER, P ;

LENOIR, C ;

ATTALI, P ;

ETIENNE, JP .

JOURNAL OF HEPATOLOGY, 1990, 11 (02) :181-184

[10] Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization:: a multicenter randomized trial [J].

Pelletier, G ;

Ducreux, M ;

Gay, F ;

Luboinski, M ;

Hagège, H ;

Dao, T ;

Van Steenbergen, W ;

Buffet, C ;

Rougier, P ;

Adler, M ;

Pignon, JP ;

Roche, A .

JOURNAL OF HEPATOLOGY, 1998, 29 (01) :129-134

← 1 →